Back to SNDX

Eversept Partners, LP → SNDX

Eversept Partners, LP SNDX Position History

Syndax Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$45.9M
Q3 2026
Peak value
$69.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$69.6M
Q1 2026$67.4M
Q2 2026$61.2M
Q3 2026$45.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$45.9M2.44M——
Q2 2026$61.2M2.80M——
Q1 2026$67.4M2.89M——
Q4 2025$69.6M3.31M——

Other funds holding SNDX

Other Eversept Partners, LP positions

UTHR

UNITED THERAPEUTICS CORP DEL

$176M
UTHR

UNITED THERAPEUTICS CORP DEL

$156.7M
UTHR

UNITED THERAPEUTICS CORP DEL

$155.9M
VERA

VERA THERAPEUTICS INC

$155.6M
EHC

ENCOMPASS HEALTH CORP

$131.5M
GLAXF

GSK PLC

$131.4M
ENSG

ENSIGN GROUP INC

$124.9M
UTHR

UNITED THERAPEUTICS CORP DEL

$123.1M